ADVERTISEMENT
Benign or Cancerous? Differentiating Mutation Types with Machine Learning
Benign or Cancerous? Differentiating Mutation Types with Machine Learning
Scientists turn to machine learning and big data approaches for precision -omics in cancer research.
Benign or Cancerous? Differentiating Mutation Types with Machine Learning
Benign or Cancerous? Differentiating Mutation Types with Machine Learning

Scientists turn to machine learning and big data approaches for precision -omics in cancer research.

Scientists turn to machine learning and big data approaches for precision -omics in cancer research.

precision medicine

Benign or Cancerous? Differentiating Mutation Types with Machine Learning
Benign or Cancerous? Differentiating Mutation Types with Machine Learning
The Scientist | Apr 27, 2023 | 2 min read
Scientists turn to machine learning and big data approaches for precision -omics in cancer research.
Learn about innovations in tissue regeneration 
Stem Cell Engineering for Tissue Regeneration
The Scientist | Oct 27, 2022 | 1 min read
Innovative strategies drive stem cell repair of organ damage.
How robotics and automation provide a streamlined, consistent, and precise solution.
Automated Pipetting for Effortless DNA Library Normalization 
INTEGRA BIOSCIENCE | Oct 14, 2022 | 1 min read
How robotics and automation provide a streamlined, consistent, and precise solution.
Human Data Era
The Human Data Era Q&A
The Scientist and Amgen | Oct 7, 2022 | 1 min read
In this webinar event, Vivienne Watson from Amgen will answer questions that delve deeper into the entire podcast series.
Human Data Era
The Human Data Era - A Special 4-Part Podcast Series
The Scientist and Amgen | Oct 7, 2022 | 1 min read
Explore the potential of human data in drug research and development.
Leveraging the Microbiome to Break Down Tumor Resistance
Leveraging the Microbiome to Break Down Tumor Resistance
The Scientist and PerkinElmer | Aug 3, 2022 | 1 min read
Mat Robinson and Mark Tangney discuss how enhancing the efficacy of immune checkpoint inhibitors improves patient outcomes.
Learn about hot topics in organoid research
Next-Level Organoids
The Scientist | Jul 22, 2022 | 1 min read
Researchers use organoid cultures in unique ways to study health and disease.
Understanding Stem Cells, One Cell at a Time
Understanding Stem Cells, One Cell at a Time
The Scientist | Jul 19, 2022 | 1 min read
An expert panel will discuss how access to single-cell resolution has shed new light on stem cell behavior and differentiation mechanisms.
A Scientific Figure of Speech
Science Philosophy in a Flash - A Scientific Figure of Speech
Iris Kulbatski, PhD | Jul 11, 2022 | 1 min read
Beate Peter shares how her “scientific bilingualism” is the driving force behind her philosophy of science.
Two babies engaged in conversation, with one shouting in the other’s ear
Nurturing Early Language Skills Prevents the Behavioral Expression of a Genetic Trait
Iris Kulbatski, PhD | Jul 11, 2022 | 4 min read
A new precision medicine approach is making life sweeter for infants unable to metabolize milk sugar.
3d illustration proteins with lymphocytes , t cells or cancer cells
New Patient Tumor Cell Models Rapidly Predict Cancer Therapy Outcomes
Jennifer Zieba, PhD | Jul 11, 2022 | 4 min read
A new benchtop microfluidic device generates patient-derived tumor micro-organospheres that allow for real-time cancer therapy decisions.
Black-Browed Albatross
Ten Minute Sabbatical
Emily Cox and Henry Rathvon | Jun 1, 2022 | 5 min read
Take a break from the bench to puzzle and peruse
Illustration of light blue speckled DNA helix on a dark background
Study Nearly Doubles Known Cancer-Linked Mutational Signatures
Jef Akst | Apr 22, 2022 | 2 min read
Analyzing the whole genome sequences of more than 18,000 tumors, researchers catalog nearly 60 new patterns of mutations that could inform cancer treatment.
Discover how biobanking accelerates cancer research
On the Path to Personalized Medicine
Thermo Fisher Scientific | Dec 3, 2021 | 1 min read
Scientists combine medical care with biobanking and research to develop personalized treatments for cancer patients.
istock image 800x560
Can mRNA Vaccine Momentum Propel Tumor Immunotherapies?
Aparna Nathan, PhD | Nov 12, 2021 | 4 min read
A guide to mRNA-based cancer vaccines and where they’re headed next
istock lung cancer
Precision Medicine Turns to Proteins for Lung Cancer Targets
Roni Dengler, PhD | Nov 9, 2021 | 2 min read
Probing the protein landscape in lung cancers reveals new therapeutic insights.
800-x-560-sept-tss
The Scientist Speaks - Homing in on New Anticancer Targets 
Sejal Davla, PhD | Sep 28, 2021 | 1 min read
Jason Sheltzer discusses cancer mechanisms leading to drug resistance and new approaches to find drug targets.
800x560-istock-1289090332
A New Model with Fully Functioning Blood Vessels Mimics Brain Cancer
Roni Dengler, PhD | Sep 10, 2021 | 2 min read
A newly developed platform may one day replace cell culture and animal models to personalize cancer treatment.
800x560-istock-1065223632
The Scientist Speaks - The Reality of Regenerative Medicine
The Scientist | Aug 26, 2021 | 1 min read
After decades of research the potential of regenerative medicine becomes a life-saving reality.
A vial containing a red blood sample is balanced on its end on a table or desk by someone wearing a blue medical glove on their right hand
New Evidence Shows COVID-19 Was in US Weeks Before Thought
Abby Olena, PhD | Jun 17, 2021 | 4 min read
Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.
ADVERTISEMENT